Lee Johnson Capital Management, LLC Bristol Myers Squibb CO Transaction History

Lee Johnson Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$68.48 - $81.09 $18,832 - $22,299	275 Added 1.52%	18,403 $1.32 Million
Q3 2022 Oct 28, 2022	BUY	$0.13 - $76.84 $28 - $16,597	216 Added 1.21%	18,128 $1.29 Million
Q2 2022 Jul 13, 2022	BUY	$72.62 - $79.98 $62,816 - $69,182	865 Added 5.07%	17,912 $1.38 Million
Q1 2022 Apr 26, 2022	BUY	$61.48 - $73.72 $8,976 - $10,763	146 Added 0.86%	17,047 $1.25 Million
Q4 2021 Jan 31, 2022	BUY	$53.63 - $62.52 $906,400 - $1.06 Million	16,901 New	16,901 $1.05 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Lee Johnson Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Lee Johnson Capital Management, LLC with notifications on news.